DURHAM, N.C., June 18, 2020 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to […]
Company expects to generate positive cash flows from operating activities, positive Free Cash Flow, and further strengthen liquidity position during […]
WALTHAM, Mass., June 18, 2020 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on […]